Advances in ADC design are rapidly reshaping the therapeutic landscape, with multispecific and multipayload formats emerging as key areas of innovation.
In this session, Longli Zhou provided an overview of emerging ADC modalities before diving into the evolving drug, clinical trial, and commercial landscapes of multispecific and multipayload ADCs. Attendees will gain insights into leading target pairs, payload mechanisms, and disease indications, including emerging trends across these areas, as well as regulatory momentum, key developers, and licensing activity shaping this rapidly advancing field.
Key Highlights:
- Overview of emerging ADC modalities and how the field is evolving beyond traditional formats
- Exploration of multispecific ADCs, including key drug, clinical, and commercial trends
- Deep dive into multipayload ADCs and where these approaches are gaining traction
Why Watch?
- Build a clear understanding of next-generation ADC formats and their strategic importance
- Stay ahead of emerging trends across multispecific and multipayload ADC development
- Gain visibility into how leading developers are differentiating their pipelines
- Learn how to effectively track and analyse evolving ADC innovation for more informed decision-making
Webinar Leaders
Longli Zhou
Senior Researcher at Beacon
You May Also Be Interested In…
Learn More About Consulting
- We are specialist life sciences market research and consultants, delivering tailored insights across the full drug development and commercialisation lifecycle.
- Combines scientific expertise, expert networks, and proprietary Beacon data to transform complex data into clear, strategic decisions.
- Provides fully customised research, spanning qualitative interviews, quantitative analysis, and desk research, aligned to your specific business objectives.
- Helps biopharma teams reduce risk, identify opportunities, and accelerate decision-making with actionable, decision-ready insights.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
